Fosfomycin—Overcoming Problematic In Vitro Susceptibility Testing and Tricky Result Interpretation: Comparison of Three Fosfomycin Susceptibility Testing Methods
<b>Background:</b> Fosfomycin (FOS) is an older antimicrobial agent newly rediscovered as a possible treatment for infections with limited therapeutic options (e.g., Gram-negative bacteria with difficult-to-treat resistance, DTR), especially in intravenous form. However, for correct usag...
Saved in:
| Main Authors: | Jan Závora, Gabriela Kroneislová, Marie Kroneisl, Václava Adámková |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/13/11/1049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro susceptibility of OXA-48, NDM, VIM and IMP enzyme- producing Klebsiella spp. and Escherichia coli to fosfomycin
by: Selay Demirci-Duarte, et al.
Published: (2020-04-01) -
Comparison of microbroth dilution and e-test methods for detecting Fosfomycin susceptibility in pseudomonas aeruginosa
by: Gongqing Song, et al.
Published: (2025-06-01) -
Antimicrobial susceptibilities of clinical bacterial isolates from urinary tract infections to fosfomycin and comparator antibiotics determined by agar dilution method and automated micro broth dilution
by: Jamie L. Dombach, et al.
Published: (2025-03-01) -
Intravenous Fosfomycin for Difficult-to-Treat Infections: A Real-Life Multicentric Study in Italy
by: Verena Zerbato, et al.
Published: (2025-04-01) -
Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae
by: Fernando Pasteran, et al.
Published: (2012-02-01)